Zhang J, Meng Y, Wang B, Wu X, et al. Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial. PLoS Med 2025;22:e1004669.
PMID: 40743286